Application Nr Approved Date Route Status External Links
NDA212099 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Nubeqa Is Indicated For The Treatment Of Patients With Non-Metastatic Castration Resistant Prostate Cancer (Nmcrpc). Nubeqa Is An Androgen Receptor Inhibitor Indicated For The Treatment Of Patients With Non-Metastatic Castration-Resistant Prostate Cancer. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Darolutamide

Comments